AV Medical Technologies Ltd. announced today that it has commenced cases in the US with its Chameleon™ angioplasty balloon catheter.

With its Supervision™ design, Chameleon™ is the only angioplasty balloon catheter that allows for simultaneous balloon inflation and injection of fluids in one device. Chameleon™ allows physicians to visualize by injecting contrast through the catheter, whether the balloon is inflated or deflated, all while maintaining wire position.

“The Chameleon™ balloon brings a number of unique advantages to dialysis access cases,” said Jeffrey Hoggard, MD, Interventional Nephrologist with Capitol Nephrology Associates in Raleigh, NC. “Combining diagnostic imaging and balloon angioplasty in one device simplifies many procedures. I am able to eliminate a number of device exchanges compared to standard balloons. The unique Chameleon™ design allows me to maintain wire access throughout the entire procedure. This provides an improved level of efficiency and confidence during the procedure.”

“This is a significant milestone for the entire AV Medical team,” said Limor Sandach, AV Medical CEO. “It is exciting to see our hard work and dedication make a difference in clinical settings. We look forward to introducing Chameleon™ to more centers as part of our limited launch in the United States.”

About AV Medical

AV Medical Technologies Ltd, a privately held medical device company headquartered in Israel, is dedicated to the development of advanced and efficient solutions in catheter-based interventions. The company is now focusing on its flagship catheter, the Chameleon™, targeted for dialysis patients undergoing routine angioplasty procedures. The company was founded by Dr. Michael Tal, Interventional Radiologist and serial entrepreneur.